Patricia Carr, SVP, Chief Accounting Officer at Jazz Pharmaceuticals plc (JAZZ), sold 158 shares at $138.16 ($22K) on 2023-08-14, disclosed to the SEC on 2023-08-15.
Seasonal sale ($22k) by SVP, Chief Accounting Officer — this insider has traded JAZZ in August in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| JAZZ | SELL | 2025-12-09 | $798K | — | Filing → |
| JAZZ | SELL | 2025-11-20 | $1.9M | — | Filing → |
| JAZZ | SELL | 2025-03-11 | $314K | — | Filing → |